Ventricular Assist Devices Market | Leading Segments, Trends, Drivers and Challenges
Market Forecast and Growth Projections 2021-2025

The Global ventricular assist devices market is expected to grow by $ 4.05 bn, accelerating at a CAGR of almost 21.46% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus.

Need more details on this market:  Request for Our FREE Sample Report

Ventricular Assist Devices Market: Segments and Leading  Regions

This research report will provide insights into the current market share of each segment along with growth projections for the next five years.

• Market is segmented Product (left and right ventricular assist devices and bi-ventricular assist devices) and Geography (North America, Europe, Asia, and ROW).
• In terms of geographic segmentation we found that 38% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Ventricular Assist Devices Market size.

Ventricular Assist Devices Market: Trends, Drivers, Challenges to impact growth

The research report looks at the impact of various trends, drivers, and challenges for market growth during the forecast period. These insights will enable clients to design a growth strategy for their business and area of operations.

• A key market driver for the Ventricular Assist Devices Market will be increasing prevalence of heart failure.
• Awareness initiatives by organizations is another factor that will be instrumental in driving market growth during the forecast period.
• One of the key challenges that market players need to contend with in order to achieve further success is the High costs associated with ventricular assist devices.

Ventricular Assist Devices Market: Vendor Analysis

• The market is concentrated.
• The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
• Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, Calon Cardio-Technology Ltd, CorWave SA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc. are some of the major market participants.

For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

The report provides insights into the following FAQs:

1. What is the market CAGR?
   The market is accelerate at a CAGR of almost 21.46%.
    
2. What is the incremental growth of the market?
   The market is expected to grow by $ 4.05 bn through 2021-2025.
    
3. What is a key factor driving this market?
   Increasing prevalence of heart failure will drive market growth over the forecast period.
    
4. What are the key regions covered in this market research report?
   North America, Europe, Asia, and ROW are the key regions featured in this research report.
    
5. Which is the leading geographic region for this market:
   38% growth will originate from North America
    
6. Who are the leading market vendors?
   The leading vendors in this market are Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Berlin Heart GmbH, Calon Cardio-Technology Ltd, CorWave SA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, and Mohawk Innovative Technology Inc.
    
7. What are the market segments covered in this report?
   The market is segmented by Product (left and right ventricular assist devices and bi-ventricular assist devices) and Geography (North America, Europe, Asia, and ROW)